Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Valuation
- About
Zivo Bioscience Inc. Warrants (ZIVOW)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/29/2025: ZIVOW (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -44.08% | Avg. Invested days 25 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 12/29/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 35.33M USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 0.04 | 52 Weeks Range 0.12 - 2.38 | Updated Date 05/26/2025 |
52 Weeks Range 0.12 - 2.38 | Updated Date 05/26/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) - |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) -13411.4% |
Management Effectiveness
Return on Assets (TTM) -948.38% | Return on Equity (TTM) -3956.02% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value - | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating 1365620 |
Shares Outstanding - | Shares Floating 1365620 | ||
Percent Insiders - | Percent Institutions - |
Upturn AI SWOT
Zivo Bioscience Inc. Warrants
Company Overview
History and Background
Zivo Bioscience Inc. Warrants represents the rights to purchase Zivo Bioscience Inc. stock. Zivo Bioscience Inc. (formerly Zivo Inc.) was founded in 2010 and focused on developing and commercializing proprietary products for the human and animal health markets. The company experienced various corporate actions, including a reverse stock split and name changes, before ultimately ceasing its primary operations and undergoing dissolution proceedings. The warrants, therefore, likely represent a claim on residual assets or a historical financial instrument tied to the company's prior existence.
Core Business Areas
- Historical Focus on Health Supplements: Zivo Bioscience Inc. previously focused on developing and marketing health and wellness products derived from algae. These products were aimed at both human and animal consumers.
Leadership and Structure
As Zivo Bioscience Inc. has undergone dissolution, its former leadership structure and current organizational status are likely inactive. Information regarding its historical leadership team would pertain to its operational period.
Top Products and Market Share
Key Offerings
- Description: A proprietary algae-based product developed for immune support in humans. Information on market share, user numbers, or revenue from this product is not readily available due to the company's dissolution. Competitors would have included other companies in the dietary supplement and immune support market.
- Product Name: ZIVOxL
- Description: An algae-based supplement designed for pet health, focusing on immune and digestive support. Similar to ZIVOxL, specific market share, user numbers, or revenue data is not publicly available. Competitors would have been in the pet supplement industry.
- Product Name: ZIVO Pet
Market Dynamics
Industry Overview
The health supplement industry, particularly the segment focused on natural and plant-based products, has seen growth driven by consumer demand for wellness and preventive healthcare. The pet supplement market has also expanded significantly with increasing pet humanization. However, this sector is highly competitive and subject to regulatory scrutiny.
Positioning
Historically, Zivo Bioscience Inc. aimed to differentiate itself through its proprietary algae-based formulations. However, given the company's dissolution, its current market positioning is null.
Total Addressable Market (TAM)
The TAM for health supplements and pet supplements is substantial, measured in billions of dollars globally. Zivo Bioscience Inc., prior to its dissolution, was a small player within these markets and is no longer positioned to capture any portion of the TAM.
Upturn SWOT Analysis
Strengths
- Proprietary algae-based formulations (historical)
- Focus on natural health solutions (historical)
Weaknesses
- Company dissolution
- Lack of current operational capacity
- Limited historical market penetration
- Dependence on a single technology (algae)
- Financial challenges leading to dissolution
Opportunities
- Potential for residual asset distribution to warrant holders (if any)
- N/A (company is dissolved)
Threats
- Irrelevance due to dissolution
- Inability to execute on any future business plans
- Market competition (historical)
Competitors and Market Share
Key Competitors
- N/A (Company is dissolved)
- N/A (Company is dissolved)
- N/A (Company is dissolved)
Competitive Landscape
The competitive landscape for Zivo Bioscience Inc. during its operational period included numerous companies in the health and pet supplement markets. Its competitive advantages were intended to stem from its unique algae-based formulations, but it faced intense competition from established and emerging brands.
Growth Trajectory and Initiatives
Historical Growth: Zivo Bioscience Inc. experienced periods of product development and market entry during its operational history. Its growth trajectory was likely characterized by efforts to gain market share in the health supplement and pet supplement sectors.
Future Projections: Future growth projections for Zivo Bioscience Inc. are not applicable due to its dissolution.
Recent Initiatives: The most significant 'recent' initiative for Zivo Bioscience Inc. would have been related to its dissolution proceedings. Prior to that, initiatives would have focused on product launches and market expansion.
Summary
Zivo Bioscience Inc. Warrants are currently tied to a dissolved company, rendering them largely speculative. The company's historical focus on algae-based health products did not lead to sustained operations. The primary 'value' for warrant holders would now be contingent on any remaining assets during the dissolution process, which is highly uncertain. Stakeholders should exercise extreme caution and understand the inherent risks associated with warrants of a defunct entity.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company filings (historical)
- Financial news archives
- Industry reports (for general market context)
Disclaimers:
This JSON output is based on publicly available historical information and the current status of Zivo Bioscience Inc. as a dissolved entity. The information regarding warrants is speculative due to the company's dissolution. This analysis is for informational purposes only and does not constitute financial advice. Investors should conduct their own due diligence.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Zivo Bioscience Inc. Warrants
Exchange NASDAQ | Headquaters Troy, MI, United States | ||
IPO Launch date 2021-05-28 | President, CEO & Chairman of the Board Mr. John Bernard Payne | ||
Sector Healthcare | Industry Biotechnology | Full time employees 7 | Website https://www.zivobioscience.com |
Full time employees 7 | Website https://www.zivobioscience.com | ||
ZIVO Bioscience, Inc., together with its subsidiaries, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. It offers poultry gut health, avian influenza, bovine mastitis, canine joint health, human immune modification, human functional food ingredients, algal biomass for human food, and biomass for supporting skin health and anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Troy, Michigan.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.